Impact of CYP2C9*3, VKORC1-1639, CYP4F2rs2108622 genetic polymorphism and clinical factors on warfarin maintenance dose in Han-Chinese patients

References

Page 1

	Year	Citations
The International HapMap Project Nature GeneticsGenetic EpidemiologyGenomicsInternational Hapmap ProjectGenome-wide Association Study	2003	6.1K
A general method for isolation of high molecular weight DNA from eukaryotes Nikolaus Blin, Darrel W. Stafford Nucleic Acids Research	1976	2.8K
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data New England Journal of Medicine	2009	1.6K
Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin Dose Mark J. Rieder, Alexander P. Reiner, Brian F. Gage, New England Journal of Medicine	2005	1.4K
Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin Charles Eby, JA Johnson, Elena Deych, Clinical Pharmacology & Therapeutics	2008	829
Randomized Trial of Genotype-Guided Versus Standard Warfarin Dosing in Patients Initiating Oral Anticoagulation Jeffrey L. Anderson, Benjamin D. Horne, Scott M. Stevens, Circulation	2007	728
The largest prospective warfarin-treated cohort supports genetic forecasting Mia Wadelius, Leslie Y. Chen, Jonatan D. Lindh, Blood	2008	551
CYP4F2 genetic variant alters required warfarin dose Michael D. Caldwell, Tarif Awad, Julie A. Johnson, Blood	2008	519
Common VKORC1 and GGCX polymorphisms associated with warfarin dose Mia Wadelius, L Y Chen, Kate Downes, The Pharmacogenomics Journal ThrombosisMedicineHematologyGenetic EpidemiologyPathology	2005	466
Association of warfarin dose with genes involved in its action and metabolism Mia Wadelius, Leslie Y. Chen, Niclas Eriksson, Human Genetics	2006	397

Page 1